KC-5600

HCT116-WRN-G729D-KI Cell Line

×
Please enable JavaScript in your browser to complete this form.
58220
Home » HCT116-WRN-G729D-KI Cell Line

Background of HCT116-WRN-G729D-KI Cell Line

The Werner syndrome ATP-dependent helicase (WRN) gene encodes a RecQ family DNA helicase-exonuclease critical for maintaining genomic stability. WRN participates in DNA repair, replication, recombination, and telomere maintenance, with its loss-of-function mutations causing Werner syndrome—a premature aging disorder characterized by genomic instability and increased cancer susceptibility. WRN-deficient cells exhibit hypersensitivity to DNA-damaging agents and impaired resolution of replication stress, highlighting its essential role in DNA damage response. Recent studies reveal synthetic lethality between WRN deficiency and microsatellite instability (MSI) in cancers, suggesting WRN as a promising therapeutic target for MSI-high tumors. Small-molecule WRN inhibitors are under investigation for selective anticancer effects. Further research is needed to elucidate WRN's multifaceted roles in aging and cancer, and to develop targeted therapies leveraging WRN dependency in specific cancer contexts.

Specifications

Catalog NumberKC-5600
Cell Line NameHCT116-WRN-G729D-KI Cell Line
Clone Number1C6
Host Cell LineHCT116
DescriptionStable HCT116 clone expressing endogenous WRN gene bearing G729D mutations, No.1C6
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing MediumRPMI1640+20% FBS+10% DMSO
Propagation MediumRPMI1640+10% FBS
Selection MarkerNA
MorphologyEpithelial
SubcultureSplit saturated culture 1:3-1:6 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative

Cell Line Generation

HCT116-WRN-G729D-KI cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of HCT116-WRN-G729D-KI cell line stable clone using PCR sequencing.

Figure 2: Characterization of HCT116-WRN-G729D-KI cell line stable clone using RT-PCR sequencing.

Figure 3. Characterization of dose-response curves for KRAS inhibitors on HCT116 and HCT116-WRN-G729D-KI cells.

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 + 10% FBS)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:3-1:6 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Oshima, J., et al. (2017). "Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions." Ageing Research Reviews, 33, 105-114.
  2. van Wietmarschen, N., et al. (2020). "BLM and WRN DNA helicases mitigate R-loops to maintain genome stability." Nature Communications, 11(1), 4281.
  3. Lieb, S., et al. (2023). "Werner syndrome helicase is a synthetic lethal target in cancers with microsatellite instability." Nature, 614(7948), 562-570.
Please enable JavaScript in your browser to complete this form.